Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

NCT00943306 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Hypercholesterolemia

Interventions

DRUG: lomitapide

Sponsor

Aegerion Pharmaceuticals, Inc.